We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Scientists "Watch” How HIV Matures into an Infection

By LabMedica International staff writers
Posted on 29 Oct 2008
After refining the sensitivity of nuclear magnetic resonance (NMR) technology, researchers have essentially visualized the HIV-1 protease mature from an inactive form into an active infection. More...
This process has never been directly visualized before.

"We actually saw the process occur,” commented Dr. Chun Tang, assistant professor of biochemistry in the University of Missouri School of Medicine (MU; Columbia, MO, USA). "This is something that has never been done before. We now understand more about the maturation process. We hope this will be a stepping stone to intervening before the infection progresses.”

The HIV-1 protease is responsible for releasing the essential building blocks of an infective HIV-1 viral particle, the cause of AIDS. The HIV-1 protease is one of the primary targets of therapeutic treatment. However, the viral enzyme is constantly mutating in an effort to gain drug resistance. "HIV-1 protease is not an active enzyme when it is first expressed in cells. It has to be activated to do its job,” Dr. Tang said. "What we were able to see is how it self-activates from an immature form when the virus is not infective into a mature form when the virus gains infectivity.”

Dr. Tang and his colleagues utilized a novel NMR method called paramagnetic resonance relaxation enhancement, and were able to see the temporary joining of two halves of HIV-1 protease precursor, something that had not been accessible before using conventional techniques. The researchers discovered that the ‘tail,' or the flanking amino acid residues, of the HIV-1 protease precursor go through a temporarily formed tunnel where the tail is cut off. At this stage, the protease becomes active, the maturation process proceeds, and the virus becomes infective.

"The more we understand about the virus, especially about the maturation into infection, the more we can do to identify novel therapeutics,” Dr. Tang said.

The findings appear in the October 2, 2008, issue of the journal Nature.

Related Links:
University of Missouri School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Thyroid Test
Anti-Thyroid EIA Test
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.